Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Goldberg

Showing results (111-120 of 175) with videos related to

Pageof 18
Sort By:
Psychiatry Research|October 20, 2006
Development and reliability of the HAM-D/MADRS interview: an integrated depression symptom rating scaleRebecca W Iannuzzo, Judith Jaeger, Joseph F Goldberg, et al.
CNS Spectrums|June 9, 2026
Nephroprotective Effects of GLP-1 Receptor Agonists in Lithium-Treated Patients: A Multinational Cohort Study Using the TriNetX NetworkRoger S McIntyre, Yanli Zhang-James, Joseph F Goldberg, et al.
Neurology|August 24, 2005
Prevalence of bipolar symptoms in epilepsy vs other chronic health disordersAlan B Ettinger, Michael L Reed, Joseph F Goldberg, et al.
The Journal of Nervous and Mental Disease|April 15, 2006
Neurocognition as a stable endophenotype in bipolar disorder and schizophreniaKatherine E Burdick, Joseph F Goldberg, Martin Harrow, et al.
Journal of Clinical Psychopharmacology|June 2, 2026
Progress on Pharmacogenetic Tests for Antidepressant Drug Selection Requires Properly Designed StudiesBruce M Cohen, Leslie Citrome, Joseph F Goldberg, et al.
The Journal of Nervous and Mental Disease|January 14, 2004
Thought disorder in schizophrenia: working memory and impaired contextMartin Harrow, Thomas H Jobe, Ellen S Herbener, et al.
Psychiatry Research|October 31, 2006
Cognition checklist for mania-revisedAaron T Beck, Michael J Colis, Robert A Steer, et al.
The Journal of Clinical Psychiatry|August 13, 2025
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel ReportChristoph U Correll, Eric D Achtyes, Martha Sajatovic, et al.
The Journal of Clinical Psychiatry|June 13, 2025
Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel ReportJoseph F Goldberg, Eric D Achtyes, Christoph U Correll, et al.
The Journal of Clinical Psychiatry|August 13, 2025
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel ReportJoseph F Goldberg, Eric D Achtyes, Martha Sajatovic, et al.
Pageof 18

Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Psychiatry Research|October 20, 2006
Development and reliability of the HAM-D/MADRS interview: an integrated depression symptom rating scaleRebecca W Iannuzzo, Judith Jaeger, Joseph F Goldberg, et al.
CNS Spectrums|June 9, 2026
Nephroprotective Effects of GLP-1 Receptor Agonists in Lithium-Treated Patients: A Multinational Cohort Study Using the TriNetX NetworkRoger S McIntyre, Yanli Zhang-James, Joseph F Goldberg, et al.
Neurology|August 24, 2005
Prevalence of bipolar symptoms in epilepsy vs other chronic health disordersAlan B Ettinger, Michael L Reed, Joseph F Goldberg, et al.
The Journal of Nervous and Mental Disease|April 15, 2006
Neurocognition as a stable endophenotype in bipolar disorder and schizophreniaKatherine E Burdick, Joseph F Goldberg, Martin Harrow, et al.
Journal of Clinical Psychopharmacology|June 2, 2026
Progress on Pharmacogenetic Tests for Antidepressant Drug Selection Requires Properly Designed StudiesBruce M Cohen, Leslie Citrome, Joseph F Goldberg, et al.
The Journal of Nervous and Mental Disease|January 14, 2004
Thought disorder in schizophrenia: working memory and impaired contextMartin Harrow, Thomas H Jobe, Ellen S Herbener, et al.
Psychiatry Research|October 31, 2006
Cognition checklist for mania-revisedAaron T Beck, Michael J Colis, Robert A Steer, et al.
The Journal of Clinical Psychiatry|August 13, 2025
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel ReportChristoph U Correll, Eric D Achtyes, Martha Sajatovic, et al.
The Journal of Clinical Psychiatry|June 13, 2025
Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel ReportJoseph F Goldberg, Eric D Achtyes, Christoph U Correll, et al.
The Journal of Clinical Psychiatry|August 13, 2025
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel ReportJoseph F Goldberg, Eric D Achtyes, Martha Sajatovic, et al.
Pageof 18